Provision of comprehensive Care and Treatment Programs by Local Indigenous Entities in The United Republic of Tanzania Under The President’s Emergency Plan for AIDS Relief (PEPFAR | CDC RFA GH13 132205CONT17

Frequently Asked Questions (FAQs)

What is this funding opportunity about?

This opportunity is a continuation cooperative agreement from the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), Center for Global Health. It focuses on sustaining and expanding comprehensive HIV care and treatment programs in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR).

What is the main purpose of the award?

The stated purpose is to support locally based, indigenous entities in delivering end-to-end HIV service delivery aligned with PEPFAR objectives. These objectives typically include diagnosing people living with HIV, rapidly linking them to care, initiating and maintaining antiretroviral therapy (ART), achieving durable viral suppression, and reducing HIV-related illness and deaths.

Is this grant intended for brand-new projects or ongoing programs?

This is a continuation opportunity designed for ongoing programming rather than starting a brand-new project from scratch. It emphasizes continuity of services for patients and communities, maintaining performance, and meeting evolving technical expectations.

What award mechanism is being used?

The mechanism is a cooperative agreement. That means CDC is expected to have substantial involvement beyond simply issuing funds, typically including close collaboration on planning, implementation support, monitoring and evaluation, quality improvement, and alignment with national strategies and PEPFAR guidance.

What does "substantial involvement" by CDC usually mean in practice?

Based on the description provided, CDC involvement commonly includes collaboration on program planning, implementation support, monitoring and evaluation activities, quality improvement efforts, and ensuring alignment with national strategies and PEPFAR guidance.

Where will the funded work take place?

The focus country is the United Republic of Tanzania, and the opportunity is oriented toward organizations operating in Tanzania.

Who is the opportunity intended to support as implementing organizations?

The opportunity is explicitly oriented toward local indigenous organizations operating in Tanzania, consistent with PEPFAR's direction toward local ownership and sustainability.

Who is eligible to apply?

The eligible applicant category is listed as "Others," with additional eligibility details referenced in the full announcement. This often signals that specific types of local entities or possibly prior recipients may be targeted, but the synopsis does not provide the complete eligibility criteria.

What types of activities might be included under "comprehensive HIV care and treatment" in a PEPFAR context?

While the summary does not list detailed program components, comprehensive care and treatment in a PEPFAR context generally includes clinical HIV services such as ART initiation and follow-up, management of advanced HIV disease, opportunistic infection screening and treatment, tuberculosis screening and linkage to TB care, and prevention and management of sexually transmitted infections. It may also include laboratory and pharmacy support, adherence and retention interventions, differentiated service delivery models, patient-centered approaches to address barriers (such as stigma, transportation, and continuity of care), routine viral load monitoring, and actions to address unsuppressed viral load (such as enhanced adherence counseling and clinical review).

Is viral load monitoring and follow-up for unsuppressed viral load part of the expected programming?

The synopsis notes that programs often incorporate routine viral load monitoring and actions to address unsuppressed viral load through enhanced adherence counseling and clinical review, in line with typical PEPFAR comprehensive treatment expectations.

How many awards does CDC anticipate making?

The notice indicates an anticipated number of 10 awards, suggesting multiple implementing partners or coverage areas.

Is there a maximum (ceiling) award amount?

The award ceiling is listed as 0. In many federal funding synopses, this typically indicates that a ceiling is not specified in the synopsis and that award amounts are determined based on the approved workplan and available funds rather than a publicly stated cap.

What is the Funding Opportunity Number (FOA number)?

The Funding Opportunity Number is CDC RFA GH13-132205CONT17.

How is this opportunity categorized?

It is categorized as continuation funding.

What CFDA number is associated with this funding?

The opportunity is tied to CFDA 93.067, which corresponds to CDC global health assistance activities.

When was the opportunity posted and when did it close?

The posting (creation) date is February 2, 2017, and the original closing date is March 31, 2017.

How does this opportunity relate to PEPFAR?

It supports comprehensive HIV care and treatment programming under PEPFAR in Tanzania, with a focus on core PEPFAR treatment outcomes such as rapid linkage to care, ART initiation and maintenance, durable viral suppression, and reductions in HIV-related illness and deaths.

Why does the synopsis emphasize local indigenous organizations?

The synopsis indicates the opportunity is oriented toward local indigenous organizations, reflecting PEPFAR's broader direction toward local ownership and sustainability of HIV service delivery.

Does the synopsis provide the full list of required program components and eligibility rules?

No. The synopsis explains the overall purpose, mechanism, and context, and notes that additional eligibility details are referenced in the full announcement. It also describes typical PEPFAR comprehensive care and treatment elements, but does not provide a complete required components list.